Home > Healthcare > Ultrasonic Scalpel Market
Ultrasonic Scalpel Market Size
Ultrasonic Scalpel Market size is expected to show notable progress during the forecast timeframe of 2024-2032 due to the introduction of advanced technologies to create cutting-edge healthcare devices.
According to IMF in 2023, the global population surpassed 8 billion in 2022, just 12 years after reaching 7 billion. The demographic shift towards an aging population, coupled with the rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes, is contributing to the surge in surgical interventions. Elderly patients often come with complex health conditions and require surgical treatments for various ailments. Ultrasonic scalpels offer precise tissue dissection and hemostasis, making them valuable tools for surgeons performing procedures on geriatric patients.
The increasing acceptance of elective surgeries, driven by greater patient awareness, accessibility to healthcare services, and advancements in medical technology, is also fueling the demand for ultrasonic scalpels. Patients are proactively seeking surgical interventions to address non-life-threatening conditions or improve their quality of life. Moreover, the rising healthcare expenditure, particularly in developed economies, is facilitating greater investment in advanced surgical equipment to meet the growing demand for elective procedures.
Ultrasonic Scalpel Market Trends
Governments across the world are taking steps to encourage the adoption of non-invasive surgeries. For example, the China-Papua New Guinea Friendship Center of Minimally Invasive Surgery was opened in December 2022 in Port Moresby to carry out minimally invasive surgical procedures in various areas, such as gynecology, general surgery, neurology, and urology. Such developments will favor the industry forecast trends.
Ultrasonic Scalpel Market Analysis
The silicone liner segment is anticipated to record a notable progression through 2032, owing to the increasing preference for medical devices that offer soft contact for scope protection and enhanced grip strength for many scope configurations. These liners exhibit excellent biocompatibility, reducing the risk of adverse reactions or tissue damage during surgical procedures. As a result, healthcare professionals are increasingly incorporating silicone liner-based ultrasonic scalpels into their surgical practices.
The hospital end-use segment is projected to capture a large revenue share during the analysis period due to the growing number of surgeries in these settings. As per data by the American College of Surgeons, about 15 million individuals in the U.S. undergo surgery every year. Hospitals not only play a vital role in enhancing the quality of patient care, but also provide them with many cost-reduction benefits.
North America ultrasonic scalpel market is poises to grow rapidly through 2032, driven by technological innovation, well-established healthcare infrastructure, and increasing medical expenditure. The region is witnessing a surge in minimally invasive surgeries, fueled by the growing prevalence of chronic diseases and the aging population. Moreover, favorable reimbursement policies and supportive regulatory frameworks further bolster industry gains in North America. Key market players are actively expanding their presence in the region through strategic collaborations, product launches, and mergers & acquisitions to capitalize on the lucrative opportunities.
Ultrasonic Scalpel Market Share
Some of the major ultrasonic scalpel companies are:
- Stryker Corporation
- Lake Region Medical (Integer Holdings)
- Axon Medical Solutions Private Ltd.
- Jinan Bakr Ultrasonic Technology Co. Ltd.
- BOWA MEDICAL UK
- EndoAfrique
- Ethicon Inc. (Johnson & Johnson)
- Tonglu Rex Medical Instrument Co. Ltd.
- Wuhan BBT Medical Tech. Co. Ltd.
- MedWOW Ltd.
Ultrasonic Scalpel Industry News
- In 2023, BT partnered with diagnostics imaging specialist due to rising interest in healthcare R&D. BT seeks to expand Axon Diagnostics’ solutions as part of its broader health-tech sector growth strategy.